CinDome Pharma
PrivateLast Round
VC Round
Jun 4, 2025
Total Funding Raised
$59M
Company Overview
CinDome Pharma is a biopharmaceutical company that develops deudomperidone (CIN-102) as a chronic treatment for gastroparesis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CinDome Pharma Comparables
Compare CinDome Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aclipse Therapeutics | 86% | |
| Renexxion, Inc. | 85% | |
| Neurogastrx | 85% | |
CinDome Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 4, 2025 | ||||
| Series B Extension | May 16, 2024 | ||||
| Series B | Apr 27, 2023 |
CinDome Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CinRx Pharma | Series B Extension, VC Round, Series B |
| Perceptive Advisors | Series B Extension, VC Round, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 4, 2025
$40M round with Perceptive Advisors and CinRx Pharma.
- May 16, 2024
$40M round with Perceptive Advisors and CinRx Pharma.
CinDome Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CinDome Pharma's valuation, stock price, and market status.